Status:

COMPLETED

Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.

Lead Sponsor:

All India Institute of Medical Sciences

Conditions:

Gallbladder Cancer

Eligibility:

All Genders

18-90 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of the study is to determine whether palliative biliary stenting improves the quality of life, of gallblader cancer patients, who present with hilar block and obstructive jaundice.

Detailed Description

For most patients with gallbladder cancer, cure is not possible and treatment should be therefore aimed at palliation of symptoms and maintaining quality of life (QOL) in the few months between diagno...

Eligibility Criteria

Inclusion

  • Patients with unresectable gallbladder cancer (Bismuth type II to IV).
  • Eastern Cooperative Oncology Group Performance (ECOG) status 0-3.

Exclusion

  • Preoperative stenting
  • ECOG status 4
  • Distant residence precluding follow up visits, or unwillingness to return for follow up.
  • Poor comprehension of the Hindi QOL questionnaire.

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00391183

Start Date

January 1 2006

End Date

December 1 2012

Last Update

July 11 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

All India Institute of Medical Sciences

New Delhi, India

Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. | DecenTrialz